IPO Trending
GLPLSME / BSEListed

Goldline Pharmaceutical Limited

Goldline Pharmaceuticals markets pharmaceutical products under the “Goldline” brand, offering a wide range of medicines across five divisions—Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. These products cater to various medical specialties including physicians, cardiologists, pediatricians, orthopedics, neurologists, critical care experts, and cancer supportive care. Instead of manufacturing medicines directly, the company works with third-party manufacturers who produce products based on its research and specifications while ensuring quality and regulatory compliance. Goldline sells its products through a network of distributors, retailers, and wholesalers, and also supports hospitals and healthcare providers with procurement and supply services. The company currently partners with 15 manufacturers and 7 distributors, with operations spread across states like Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar.

₹41 - ₹43840.81x sub
Listed Price59.75
Listing Gain+38.95%
TimelineBookbuilding IPO
Open12 May 2026
Close14 May 2026
Allotment15 May 2026
Listing19 May 2026

Quota Reservation Portions

AnchorPortion: 7,32,000 shares
27.11%
QIBPortion: 5,40,000 shares
20%
HNIPortion: 3,90,000 shares
14.44%
RetailPortion: 9,00,000 shares
33.33%
Market MakerPortion: 1,38,000 shares
5.11%

Minimum Application Bracket Matrix

Retail2 lots / 6,000 shares
₹2,58,000
sHNI3 lots / 9,000 shares
₹3,87,000
bHNI8 lots / 24,000 shares
₹10,32,000

About the Company

Goldline Pharmaceuticals markets pharmaceutical products under the “Goldline” brand, offering a wide range of medicines across five divisions—Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. These products cater to various medical specialties including physicians, cardiologists, pediatricians, orthopedics, neurologists, critical care experts, and cancer supportive care. Instead of manufacturing medicines directly, the company works with third-party manufacturers who produce products based on its research and specifications while ensuring quality and regulatory compliance. Goldline sells its products through a network of distributors, retailers, and wholesalers, and also supports hospitals and healthcare providers with procurement and supply services. The company currently partners with 15 manufacturers and 7 distributors, with operations spread across states like Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar.

Company Promoters

Amol Laxmikant MujumdarSwapan Premprakash Khandelwal